human
enteroviru
emerg
pathogen
caus
sever
respiratori
diseas
associ
case
paralysi
especi
among
children
first
isol
sampl
obtain
california
four
children
pneumonia
bronchiol
schiebl
et
al
past
year
infect
outbreak
report
itali
unit
state
germani
china
sever
countri
esposito
et
al
farrel
et
al
reich
et
al
zhang
et
al
record
number
confirm
case
http
unfortun
vaccin
prevent
medicin
treatment
current
avail
futur
outbreak
mainli
due
fact
inform
host
factor
requir
replic
scarc
belong
enteroviru
famili
picornavirida
genu
enteroviru
nonenvelop
positivesens
singlestrand
rna
virus
approxim
nt
contain
larg
open
read
frame
encod
polyprotein
cleav
yield
correspond
viral
protein
base
molecular
biolog
characterist
four
human
enteroviru
hev
speci
current
design
heva
b
c
oberst
et
al
b
repres
heva
serotyp
human
enteroviru
primari
caus
agent
hand
foot
mouth
diseas
hfmd
associ
recent
outbreak
asia
liu
et
al
wang
et
al
assign
hevd
serotyp
unlik
enterovirus
acid
labil
biolog
similar
human
rhinovirus
associ
respiratori
diseas
smura
et
al
featur
pathogen
mechan
mani
virus
facilit
replic
interact
host
factor
regul
cell
cycl
progress
exampl
discov
dna
virus
retrovirus
rna
virus
dna
virus
replic
nucleu
extens
investig
regard
control
cell
cycl
host
cell
exampl
small
dna
virus
includ
simian
viru
decaprio
et
al
adenoviru
howe
et
al
eckner
et
al
human
papillomaviru
wer
et
al
lack
polymeras
use
host
polymeras
promot
entri
cell
phase
phase
larg
dna
virus
exampl
herpesvirus
induc
arrest
order
avoid
compet
cellular
dna
replic
resourc
flemington
cell
cycl
regul
also
observ
retrovirus
like
dna
virus
replic
nucleu
vpr
protein
human
immunodefici
viru
type
respons
elicit
cell
cycl
arrest
phase
et
al
goh
et
al
furthermor
rna
virus
whose
primari
site
replic
normal
cytoplasm
also
demonstr
interfer
host
cell
cycl
infecti
bronchiti
viru
ibv
induc
arrest
favor
viral
replic
dove
et
al
li
et
al
mous
hepat
viru
mhv
chen
makino
sever
acut
respiratori
syndrom
coronaviru
sarscov
protein
induc
cell
cycl
arrest
phase
yuan
et
al
previou
studi
found
human
coxsackieviru
manipul
host
cell
cycl
phase
order
promot
viral
replic
yu
et
al
howev
potenti
manipul
host
cell
cycl
associ
higher
lethal
recent
largescal
outbreak
previous
character
current
studi
examin
effect
cell
cycl
statu
viral
replic
well
impact
viru
host
cell
cycl
data
show
replic
integr
associ
host
cell
cycl
though
pattern
regul
differ
distinctli
result
increas
understand
pathogen
mechan
enterovirus
provid
potenti
target
treatment
prevent
enterovirusrel
diseas
fermon
atcc
atcc
atcc
strain
strain
report
previous
wang
et
al
virus
propag
human
rhabdomyosarcoma
rd
cell
supernat
harvest
store
human
embryon
kidney
cell
hek
cell
rd
cell
purchas
atcc
manassa
va
usa
use
accord
previou
studi
wang
et
al
cell
maintain
dulbecco
modifi
eagl
medium
dmem
hyclon
logan
ut
usa
supplement
fetal
bovin
serum
fb
gibco
brl
grand
island
ny
usa
viral
titer
determin
measur
tissu
cultur
infect
dose
microtitr
assay
use
rd
cell
describ
gay
et
al
rd
cell
seed
incub
h
plate
viruscontain
supernat
serial
dilut
diluent
viru
ad
per
well
octupl
experiment
endpoint
reach
cytopath
effect
observ
per
day
accord
reedmuench
method
reed
viral
titer
determin
base
assumpt
materi
produc
plaqu
form
unitsml
cell
mockinfect
infect
multipl
infect
moi
h
viru
adsorpt
cell
wash
phosphatebuff
salin
pb
one
time
ad
fresh
cultur
medium
subconflu
cultur
rd
cell
synchron
phase
serum
depriv
et
al
approxim
cell
plate
plate
maintain
serumfre
medium
h
viru
infect
fresh
dmem
ad
releas
cell
order
observ
effect
cell
cycl
viru
growth
subconflu
cultur
rd
cell
synchron
phase
serum
depriv
h
et
al
sphase
synchron
final
concentr
mm
thymidin
sigma
ad
helt
harri
yu
et
al
h
synchron
ngml
nocodazol
sigma
ad
et
al
yu
et
al
h
sustain
cellcycl
arrest
viru
infect
cell
treat
fresh
mm
thymidin
ngml
nocodazol
indic
time
propidium
iodid
pi
stain
use
measur
nuclear
dna
content
accord
previou
studi
yu
et
al
firstli
cell
collect
fix
ml
cold
ethanol
overnight
resuspend
pi
stain
buffer
pi
sigma
rnase
pb
h
fluorescenceactiv
cell
sort
facscan
bd
use
analyz
pistain
cell
least
cell
count
sampl
modfit
lt
version
veriti
softwar
hous
perform
data
analysi
virusinfect
mockinfect
cell
collect
variou
time
infect
wash
pb
previous
describ
yu
et
al
follow
antibodi
use
western
blot
analys
cell
signal
proteintech
cell
signal
cell
signal
anticyclind
cell
signal
boster
santa
cruz
antihiston
genscript
secondari
antibodi
mous
rabbit
obtain
jackson
immuno
research
work
carri
design
pcrclean
area
previous
describ
yu
et
al
rna
extract
infect
uninfect
cell
use
trizol
reagent
gibcobrl
rockvil
md
isol
specifi
manufactur
rna
dnasetr
dnase
irnasefre
ambion
remov
contamin
dna
ng
total
rna
reversetranscrib
oligo
dt
primer
use
high
capac
cdna
rt
kit
appli
biosystem
cdna
reaction
specifi
manufactur
quantit
pcr
templat
cdna
ad
reaction
sybr
green
pcr
master
mix
appli
biosystem
primer
tabl
amplif
carri
use
abi
prism
cycl
follow
condit
initi
denatur
min
cycl
min
fold
chang
calcul
rel
gapdh
use
method
cell
lysat
examin
histon
elisa
kit
meiyan
shanghai
china
accord
manufactur
instruct
micropl
quantifi
use
micropl
reader
biorad
hercul
ca
usa
target
protein
express
normal
histon
express
statist
differ
analyz
use
student
ttest
analysi
except
dosedepend
test
figur
pearson
correl
coeffici
data
present
mean
standard
deviat
sd
pvalu
consid
statist
signific
viral
replic
often
integr
associ
cell
cycl
statu
host
cell
feuer
et
al
explor
possibl
benefit
differ
cell
cycl
phase
viral
replic
synchron
cell
differ
phase
assess
viral
replic
virul
first
assess
effect
synchron
serum
depriv
darzynkiewicz
et
al
rd
cell
cultur
either
serum
medium
control
serumfre
medium
synchron
h
cell
infect
titer
moi
fermon
strain
mockinfect
h
either
serum
medium
serumfre
medium
ad
anoth
h
figur
previous
report
et
al
serum
depriv
induc
obviou
arrest
assess
flow
cytometri
p
figur
h
postinfect
viral
entri
stage
genom
rna
level
significantli
differ
control
serumstarv
cell
figur
howev
h
post
infect
viral
replic
stage
time
viral
rna
detect
serumstarv
cell
control
cell
p
figur
furthermor
h
viral
product
stage
infecti
particl
time
higher
supernat
phasesynchron
cell
supernat
control
cell
p
figur
result
suggest
arrest
affect
viral
entri
promot
viral
replic
product
determin
whether
viral
replic
product
also
elev
phase
cell
cycl
effect
phase
synchron
assess
cell
cultur
medium
synchron
phase
cultur
mm
thymidin
h
cell
mock
infect
infect
moi
h
fresh
cultur
medium
mm
thymidin
ad
anoth
h
figur
thymidin
induc
obviou
phase
arrest
p
figur
genom
rna
level
remain
similar
phasesynchron
cell
control
nonsynchron
cell
h
postinfect
figur
h
postinfect
p
figur
furthermor
valu
h
postinfect
equival
phasesynchron
cell
supernat
control
cell
supernat
p
figur
result
suggest
sphase
arrest
affect
viral
entri
replic
product
assess
effect
phase
synchron
cell
cultur
medium
treat
ngml
nocodazol
h
cell
mock
infect
infect
moi
h
cultur
fresh
medium
ngml
nocodazol
anoth
h
figur
nododazol
induc
obviou
arrest
p
figur
h
postinfect
signific
differ
genom
rna
level
control
phasesynchron
cell
figur
howev
h
postinfect
genom
level
lower
synchron
cell
control
cell
p
figur
furthermor
h
postinfect
supernat
phasesynchron
cell
obvious
lower
control
cell
p
figur
therefor
result
suggest
synchron
affect
viral
entri
inhibit
viral
replic
product
given
replic
product
depend
cell
cycl
next
ask
whether
might
abil
manipul
host
cell
cycl
facilit
product
rd
cell
infect
fermon
stain
moi
cell
collect
cell
cycl
distribut
analysi
h
obviou
increas
percentag
cell
observ
cell
compar
mockinfect
cell
increas
p
figur
therefor
manipul
host
cell
accumul
preferenti
phase
rather
favor
viral
product
though
latter
experi
perform
use
fermon
strain
isol
children
pneumonia
bronchiol
unit
state
schiebl
et
al
zhang
et
al
sever
recent
strain
viru
isol
current
circul
strain
similar
fermon
strain
clinic
characterist
genom
structur
known
whether
similar
virul
abil
manipul
cell
cycl
therefor
compar
strain
fermon
strain
normal
cultur
condit
rd
cell
infect
three
strain
viru
moi
h
respect
strain
time
higher
higher
fermon
strain
figur
result
suggest
virul
increas
time
could
explain
recent
rise
incid
enterovirusrel
diseas
esposito
et
al
farrel
et
al
reich
et
al
zhang
et
al
next
assess
cell
cycl
distribut
rd
cell
infect
current
circul
strain
moi
h
obviou
increas
percentag
cell
phase
observ
increas
p
figur
increas
p
figur
strain
also
caus
correspond
increas
ratio
cell
increas
increas
p
figur
therefor
current
circul
strain
possess
increas
virul
similar
abil
fermon
strain
skew
cell
cycl
toward
phase
facilit
viral
product
understand
mechan
manipul
host
cell
cycl
assess
whether
could
regul
cell
cycl
exit
phase
rd
cell
synchron
serum
starvat
h
mockinfect
infect
fermon
strain
h
cell
stimul
fb
order
trigger
cell
cycl
reentri
phase
h
mitogen
stimul
serum
mockinfect
cell
progress
synchron
phase
contrast
major
rd
cell
remain
phase
h
time
period
without
entri
p
figur
therefor
result
support
model
infect
regul
cell
cycl
prevent
entri
phase
cyclincdk
complex
known
regul
cell
cycl
progress
sherr
identifi
key
molecul
signal
pathway
may
mediat
inhibit
cell
entri
phase
examin
protein
express
profil
host
sphase
protein
western
blot
rd
cell
h
postinfect
among
molecul
cyclind
mediat
cell
cycl
progress
mediat
cell
cycl
transit
phase
hind
et
al
express
chang
express
increas
h
postinfecion
figur
significantli
decreas
virusinfect
cell
compar
mockinfect
cell
h
postinfect
figur
g
furthermor
mrna
level
decreas
infect
howev
signific
differ
viru
mockinfect
group
cyclind
mrna
level
figur
therefor
infect
inhibit
host
express
sever
cell
cycl
protein
consist
abil
inhibit
phase
entri
modul
like
occur
transcript
posttranscript
cyclind
examin
potenti
effect
viru
infect
cell
cycl
transit
phase
rd
cell
treat
ngml
nocodazol
medium
h
phase
synchron
cell
mock
infect
infect
moi
h
next
cell
treat
addit
h
ngml
nocodazol
fresh
medium
nocodazol
induc
obviou
cell
cycl
arrest
vs
p
howev
infect
h
percentag
cell
decreas
vs
p
percentag
cell
increas
vs
p
figur
therefor
infect
also
regul
cell
cycl
promot
exit
phase
consist
find
express
mediat
progress
coverley
et
al
yam
et
al
regul
infect
figur
g
decreas
mrna
level
upon
infect
transit
fromp
mrna
express
significantli
regul
figur
therefor
viru
promot
cell
cycl
exit
entri
modifi
pathway
entri
transcript
level
posttransl
level
previou
studi
conclud
exogen
express
viral
nonstructur
protein
rnadepend
rna
polymeras
mediat
cell
cycl
arrest
phase
yu
et
al
given
find
examin
whether
nonstructur
protein
abil
mediat
cell
cycl
alter
transfect
express
vector
induc
arrest
increas
percentag
cell
increas
p
correspond
increas
ratio
increas
p
figur
furthermor
extent
increas
percentag
cell
depend
dose
vector
r
p
ratio
also
depend
dose
vector
r
p
figur
result
suggest
nonstructur
protein
contribut
arrest
also
examin
potenti
role
nonstructur
protein
cell
cycl
regul
transfect
high
dose
express
vector
decreas
percentag
cell
phase
decreas
increas
ratio
cell
increas
p
figur
high
dose
transfect
also
increas
percentag
cell
phase
although
chang
cell
cycl
profil
dosedepend
ratio
dosedepend
r
p
figur
result
suggest
nonstructur
protein
may
contribut
enhanc
cell
cycl
exit
phase
infect
verifi
find
evalu
mechan
cell
cycl
regul
transfect
perform
western
blot
assay
examin
effect
express
cyclerel
protein
consist
cell
cycl
analys
downregul
express
cyclind
figur
downregul
express
figur
therefor
nonstructur
protein
facilit
exit
nonstructur
protein
mediat
arrest
figur
serotyp
hevd
serotyp
heva
enterovirus
demonstr
synchron
promot
viral
replic
figur
howev
previou
studi
determin
synchron
inhibit
viral
replic
exclud
experiment
variat
explan
dispar
respons
virus
synchron
perform
sidebysid
comparison
two
enterovirus
result
confirm
serum
treatment
induc
synchron
figur
b
synchron
opposit
effect
two
virus
figur
h
infect
viral
genom
mrna
level
time
higher
serumstarv
cell
control
cell
p
figur
howev
h
infect
viral
genom
mrna
level
time
lower
serumstarv
cell
p
figur
furthermor
h
infect
time
higher
phasesynchron
cell
control
cell
vs
p
figur
time
lower
phasesynchron
cell
control
cell
vs
p
figur
result
confirm
arrest
differ
effect
two
enterovirus
synchron
nocodazol
shown
inhibit
fermon
strain
studi
figur
previou
studi
yu
et
al
determin
whether
similar
effect
synchron
observ
current
circul
strain
cell
treat
ngml
nocodazol
medium
h
infect
moi
h
treat
ngml
nocodazol
fresh
medium
anoth
h
result
demonstr
nocodazol
treatment
decreas
genom
rna
level
figur
valu
figur
fermon
suggest
viru
inhibit
upon
synchron
may
similar
enterovirus
confirm
synchron
inhibit
assess
effect
altern
agent
exert
arrest
vitro
pseudolar
acid
b
pab
diterpen
acid
isol
root
trunk
bark
pseudolarix
kaempferi
grord
pinacea
yu
et
al
pab
confirm
promot
arrest
h
figur
assess
effect
pab
viral
rna
virul
rd
cell
infect
strain
moi
h
treat
pab
h
pab
decreas
genom
rna
level
control
p
figur
control
p
figur
furthermor
pab
decreas
valu
decreas
p
figur
decreas
p
figur
result
confirm
arrest
inhibit
strain
suggest
common
approach
therapeut
intervent
might
potenti
target
broader
rang
enterovirus
enteroviru
usual
caus
mild
sever
respiratori
ill
includ
runni
nose
sneez
cough
bodi
muscl
ach
wheez
difficulti
breath
case
infant
children
teen
death
although
first
identifi
california
number
peopl
one
breakout
confirm
infect
much
greater
number
report
previou
year
http
hard
predict
whether
emerg
futur
outbreak
valu
resolv
pathogen
mechan
obviou
studi
investig
pathogen
mechan
reveal
relationship
viru
infect
host
cell
cycl
assess
possibl
cell
cycl
statu
affect
viral
replic
first
synchron
cell
result
demonstr
arrest
promot
replic
increas
viral
virul
without
affect
viru
entri
also
assess
effect
phase
phase
synchron
viral
product
result
suggest
phase
synchron
affect
viral
entri
replic
product
compar
control
treatment
synchron
inhibit
viral
replic
decreas
viral
virul
affect
viru
entri
result
indic
phase
favor
replic
phase
support
viral
product
phase
inhibitori
host
viral
product
given
phase
support
product
would
advantag
viru
manipul
host
cell
cycl
increas
viral
product
inde
fermon
strain
display
signific
abil
increas
percentag
cell
phase
fermon
strain
isol
unit
state
schiebl
et
al
current
circul
strain
includ
may
relev
current
human
health
therefor
examin
whether
two
current
circul
strain
similar
abil
manipul
cell
cycl
result
confirm
circul
strain
manipul
cell
cycl
similar
manner
fermon
strain
though
current
strain
higher
virul
fermon
therefor
year
evolut
still
possess
abil
arrest
cell
phase
virul
increas
pinpoint
caus
accumul
upon
infect
analyz
transit
cell
cycl
releas
mockinfect
cell
enter
phase
cell
still
accumul
phase
thu
demonstr
infect
prevent
phase
entri
phase
furthermor
synchron
infect
promot
cell
cycl
transit
phase
therefor
infect
regul
cell
cycl
arrest
promot
phase
entri
inhibit
phase
departur
analyz
mechan
host
cell
cycl
manipul
assess
express
cyclin
cdk
known
form
complex
regul
cell
cycl
progress
oosthuysen
et
al
exampl
regul
progress
regul
sphase
entri
hind
et
al
regul
sphase
progress
replac
cyclin
coverley
et
al
yam
et
al
prevent
cell
cycl
transit
yu
et
al
adeyemi
pintel
demonstr
cyclind
downregul
infect
could
explain
abil
inhibit
transit
phase
furthermor
express
downregul
infect
consist
abil
promot
transit
therefor
express
cell
cyclerel
protein
support
result
suggest
induc
arrest
regul
phase
entri
exit
also
analyz
whether
regul
protein
express
occur
mrna
level
found
downregul
cell
cycl
protein
indic
regul
cellular
factor
relat
cell
cycl
occur
partli
transcript
level
mostli
occur
posttransl
level
viral
nonstructur
protein
often
essenti
viral
replic
also
evalu
whether
might
exert
host
cell
cycl
regulatori
function
via
viral
nonstructur
protein
result
confirm
nonstructur
protein
increas
percentag
cell
phase
decreas
express
phase
relatedcel
cycl
protein
cyclind
decreas
percentag
cell
phase
decreas
express
protein
find
rais
possibl
nonstructur
protein
may
function
coordin
context
infect
enhanc
percentag
cell
increas
ratio
note
nonstructur
protein
mediat
cell
cycl
arrest
phase
mediat
cell
cycl
although
detail
reason
differ
clear
specul
amino
acid
sequenc
might
bind
target
respons
function
cell
cycl
arrest
differ
amino
acid
sequenc
might
bind
differ
factor
respons
differ
abil
cell
cycl
regul
part
investig
futur
current
studi
demonstr
phase
arrest
requir
product
howev
previou
studi
shown
opposit
effect
yu
et
al
differ
surpris
given
belong
picornavirida
famili
confirm
differ
activ
two
virus
analyz
side
side
result
confirm
synchron
promot
viral
product
inhibit
viral
product
therefor
manipul
host
cell
cycl
process
outcom
cell
cycl
manipul
entir
differ
could
explain
vari
characterist
epidem
region
europ
asia
clinic
symptom
epidem
size
meanwhil
result
serv
remind
differ
enterovirus
may
requir
differ
therapeut
treatment
target
differ
set
host
factor
unfortun
reason
differ
clear
specul
host
factor
gener
kept
high
level
phase
requir
product
requir
host
factor
gener
kept
high
level
phase
nonstructur
oblig
two
virus
regul
host
cell
cycl
replic
main
goal
analyz
mechan
pathogenesi
identifi
new
strategi
prevent
treat
diseas
addit
experi
explor
synchron
approach
inhibit
replic
differ
strain
result
demonstr
addit
effect
fermon
strain
synchron
nocodazol
inhibit
replic
virul
addit
pab
anoth
agent
induc
arrest
also
significantli
inhibit
product
nocodazol
also
shown
effect
inhibit
product
yu
et
al
medicin
induc
arrest
might
consid
common
approach
inhibit
differ
type
antienteroviru
infect
provid
new
direct
antienteroviru
drug
develop
studi
obtain
ethic
approv
ethic
committe
first
hospit
jilin
univers
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
